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background:  Cardiac arrhythmias associated with heart failure (HF) cause a significant number of deaths worldwide, and the implantable 
cardioverter defibrillator (ICD) has emerged as an important treatment option for patients at risk of sudden cardiac death. Nevertheless, 
current risk stratification is suboptimal. Abnormal expression of the cardiac sodium channel (SCN5A) contributes to the arrhythmic risk in 
HF, blood SCN5A variant levels correlate with the levels measured in myocardial tissue, and circulating SCN5A variants levels are excellent 
predictors of an appropriate ICD intervention.
Methods:  Here, we report that RNA binding protein HuR contributes to SCN5A mRNA stability by binding to the 3’ untranslated region, and 
circulating HuR mRNA levels are inversely related to ICD intervention in HF patients by using RT-qPCR analysis. 
results:  The mRNA level of HuR decreased 38.9% (P=0.034) in peripheral white blood cells of HF patients with an appropriate ICD 
therapy as compared with that in normal control population. The decrease of HuR mRNA correlated with a reduction of wild-type SCN5A 
mRNA expression in these patients. The area under the Receiver operating characteristics analysis (ROC) curve for prediction of an ICD 
event using HuR levels was 0.93 (95% CI 0.78, 1.00, asymptotic Sig.=0.018). At the optimal cutoff, the corresponding maximum sensitivity 
and specificity were 1.0 (95% CI: 0.48, 1.00) and 0.9 (0.36, 1.00), respectively.
Conclusion:  Our results demonstrate an additional layer of SCN5A posttranscriptional regulation in addition to alternative splicing that 
can contribute to arrhythmic risk in HF. In addition, our results suggest that circulating HuR protein assessment may be used to stratify 
arrhythmic risk in HF patients and may help identify those patients with HF who might benefit most from device implantation. 
